Ptosis is the drooping of one or both upper eyelids, which may result in vision obstruction and may cause the patient to appear sleepy or tired. This condition can affect children and adults. After assessing the severity of ptosis, we will tailor a treatment plan to meet your specific needs.
The top most photo is a patient who was post-op week one from ptosis repair, with minimal swelling.
This patient also underwent ptosis repair. The top photo was taken pre-operatively while the bottom photo was taken two weeks after surgery.
This patient underwent combined droopy eyelid repair and upper eyelid blepharoplasty to address her excess skin. The bottom photo was taken two weeks postoperatively.
This patient underwent combined droopy eyelid repair and upper eyelid blepharoplasty to address his excess skin. The bottom photo was taken two weeks postoperatively.
This patient required frontalis slings to address his droopy eyelids and an eyelid blepharoplasty to address his excess eyelid skin. The bottom photo was taken two weeks postoperatively.
This patient had excess eyelid skin and xanthalesma (yellow cholesterol deposits underneath the eyelids). She underwent a combined procedure (xanthalesma removal and upper eyelid blepharoplasty); the bottom photo was taken two weeks postoperatively.
Basal cell carcinoma involving the upper/lower eyelids and medial canthus (1); Basal cell carcinoma involving the lower eyelid and punctum (2); Melanoma of the lower eyelid (3); Papilloma of the upper eyelid (4); Melanoma in-situ of the lower eyelid (5); Basal cell carcinoma (morpheaform subtype) involving the medial canthus and lower eyelid (6)
Thyroid eye disease (also known as Graves’ disease) is a condition in which the body’s immune system attacks the extraocular muscles of the eye and the surrounding orbital tissues. This can lead to a swollen and “bulging” appearance of the eyes, and if left unattended, can eventually cause blindness.
Treatment for this condition may be medical and/or surgical.
Teprotumumab (Tepezza®) was used to treat this patient's proptosis. The top photo depicts her appearance prior to Tepezza® administration and the bottom photo was taken just after her third infusion of the medication.
When this patient presented to Dr. Ford, she was rapidly losing vision from her Graves' (thyroid eye) disease. She had significant exophthalmos (bulging eyes), resulting in markedly increased intraocular pressures, and evidence of compressive optic neuropathy as seen on her visual field exam (see below). She also had double vision and eye pain.
Dr. Ford admitted the patient to the hospital for high-dose intravenous steroids and prescribed Tepezza. Just one treatment of Tepezza has resulted in remarkable improvement.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.